Viral Hepatitis

Hutton, D., Toy, M., Yang, D., Zhang, H., Handanagic, S., Armstrong, P., Wasley, A., Menzies, N., Pham, H., Salomon, J., & So, S. (2024). Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13982

Zhu, L., Thomas, W., Hagan, L., Randall, L., Rudolph, A., Young, A., Havens, J., Salomon, J., & Linas, B. (2024). Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs-A network modeling study. International Journal of Drug Policy, (130), 104539. https://doi.org/10.1016/j.drugpo.2024.104539

Pham, T., Toy, M., Hutton, D., Thompson, W., Conners, E., Nelson, N., Salomon, J., & So, S. (2023). Gaps and disparities in chronic hepatitis B monitoring and treatment in the United States, 2016-2019. Medical Care, 61(4), 247-253. https://doi.org/10.1097/MLR.0000000000001825

Pham, T., Maria, N., Cheng, V., Nguyen, B., Toy, M., Hutton, D., Conners, E., Nelson, N., Salomon, J., & So, S. (2023). Gaps in prenatal hepatitis B screening and management of HBsAg positive pregnant persons in the United States. American Journal of Preventative Medicine, 65(1), 52-29. https://doi.org/10.1016/j.amepre.2023.01.041

So, S., Terrault, N., & Conners, E. (2023). Universal adult hepatitis B screening and vaccination as the path to elimination. JAMA, 329(19), 1639–1640. https://doi.org/10.1001/jama.2023.2806

Toy, M., Hutton, D., Harris, A., Nelson, N., Salomon, J., & So, S. (2022). Cost-effectiveness of one-time universal screening for chronic hepatitis B infection in adults in the United States. Clinical Infectious Diseases, 74(215), 210–217. https://doi.org/10.1093/cid/ciab405

Hutton , D., Toy, M., Salomon, J., Conners, E., Nelson, N., Harris, A., & So, S. (2022). Cost-effectiveness of hepatitis B testing and vaccination of adults seeking care for sexually transmitted infections. Sexually Transmitted Diseases, 49(7), 517-525. https://doi.org/10.1097/OLQ.0000000000001632

Bellerose, M., Zhu, L., Hagan, L., Thompson, W., Randall, L., Malyuta, Y., Salomon, J., & Linas, B. (2021). A review of network simulation models of hepatitis C virus and HIV among people who inject drugs. International Journal of Drug Policy, 88. https://doi.org/10.1016/j.drugpo.2019.10.006

Assoumou, S., Tasillo, A., Vellozzi, C., Eftekhari Yazdi, G., Wang, J., Nolen, S., Hagan, L., Thompson, W., Randall, L., Strick, L., Salomon, J., & Linas, B. (2020). Cost-effectiveness and budgetary impact of hepatitis C virus testing, treatment, and linkage to care in US prisons. Clinical Infectious Diseases, 70(7), 1388-1396. https://doi.org/10.1093/cid/ciz383

Zhu, L., Menzies, N., Wang, J., Linas, B., Goodreau, S., & Salomon, J. (2020). Estimation and correction of bias in network simulations based on respondent-driven sampling data. Scientific Reports, 10(1), 6348. https://doi.org/10.1038/s41598-020-63269-0

Assoumou, S., Wang, J., Nolen, S., Eftekhari Yazdi , G., Mayer, K., Puro, J., Salomon, J., & Linas, B. (2020). HCV testing and treatment in a national sample of US federally qualified health centers during the opioid epidemic. Journal of General Internal Medicine, 35(5), 1477-1483. https://doi.org/10.1007/s11606-020-05701-9

Assoumou, S., Nolen, S., Hagan, L., Wang, J., Eftekhari Yazdi, G., Thompson, W., Mayer, K., Puro, J., Zhu, L., Salomon, J., & Linas, B. (2020). Hepatitis C management at federally qualified health centers during the opioid epidemic: A cost-effectiveness study. American Journal of Medicine, 133(11), e641-e658. https://doi.org/10.1016/j.amjmed.2020.05.029

Assoumou, S., Wang, J., Tasillo, A., Eftekhari Yazdi , G., Tsui, J., Strick, L., & Linas, B. (2019). Hepatitis C testing and patient characteristics in Washington state’s prisons between 2012 and 2016. American Journal of Preventative Medicine, 56(1), 8-16. https://doi.org/10.1016/j.amepre.2018.08.016

Epstein, R., Wang, J., Hagan, L., Mayer, K., Puro, J., Linas, B., & Assoumou, S. (2019). Hepatitis C virus antibody testing among 13- to 21-year-olds in a large sample of US federally qualified health centers. JAMA, 322(22), 2245-2248. https://doi.org/10.1001/jama.2019.16196

Tasillo, A., Eftekhari Yazdi, G., Nolen, S., Schillie, S., Vellozzi, C., Epstein, R., Randall, L., Salomon, J., & Linas, B. (2019). Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care. Obstetrics and Gynecology, 133(2), 289-300. https://doi.org/10.1097/AOG.0000000000003062

Epstein, R., Wang, J., Mayer, K., Puro, J., Horsburgh, C., Linas, B., & Assoumou, S. (2018). HCV screening practices among adolescents and young adults in a national sample of federally qualified health centers in the United States. Open Forum Infectious Diseases, 5, S74. https://doi.org/10.1093/ofid/ofy209.178

Epstein, R., Sabharwal, V., Wachman, E., Saia, K., Vellozzi, C., Hariri, S., & Linas, B. (2018). Perinatal transmission of hepatitis C virus: Defining the cascade of care. Journal of Pediatrics, 203, 34-40.e1. https://doi.org/10.1016/j.jpeds.2018.07.006

Barocas, J., Tasillo, A., Eftekhari Yazdi, G., Wang, J., Vellozzi, C., Hariri, S., Isenhour, C., Randall, L., Ward, J., Mermin, J., Salomon, J., & Linas, B. (2018). Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States. Clinical Infectious Diseases, 67(4), 549-556. https://doi.org/10.1093/cid/ciy098

Barocas, J., Wang, J., White, L., Tasillo, A., Salomon, J., Freedberg, K., & Linas, B. (2017). Hepatitis C testing increased among baby boomers following the 2012 change to CDC testing recommendations. Health Affairs, 36(12), 2142-2150. https://doi.org/10.1377/hlthaff.2017.0684